Cargando…
Safety of azithromycin in infants under six months of age in Niger: A community randomized trial
BACKGROUND: Mass azithromycin distribution reduces under-5 child mortality. Trachoma control programs currently treat infants aged 6 months and older. Here, we report findings from an infant adverse event survey in 1–5 month olds who received azithromycin as part of a large community-randomized tria...
Autores principales: | Oldenburg, Catherine E., Arzika, Ahmed M., Maliki, Ramatou, Kane, Mohamed Salissou, Lebas, Elodie, Ray, Kathryn J., Cook, Catherine, Cotter, Sun Y., Zhou, Zhaoxia, West, Sheila K., Bailey, Robin, Porco, Travis C., Keenan, Jeremy D., Lietman, Thomas M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258425/ https://www.ncbi.nlm.nih.gov/pubmed/30419040 http://dx.doi.org/10.1371/journal.pntd.0006950 |
Ejemplares similares
-
Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial
por: Arzika, Ahmed M., et al.
Publicado: (2019) -
Malaria Parasitemia and Nutritional Status during the Low Transmission Season in the Presence of Azithromycin Distribution among Preschool Children in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2020) -
Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020) -
Effect of Mass Azithromycin Distributions on Childhood Growth in Niger: A Cluster-Randomized Trial
por: Arzika, Ahmed M., et al.
Publicado: (2021) -
Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial
por: Keenan, Jeremy D, et al.
Publicado: (2020)